Table 1 Demographic information of phentermine and overweight cohorts after Propensity Score Matching.
Variable | Phentermine [SD] or (%) (N = 26,611) | Overweight [SD] or (%) (N = 26,611) | Standard difference |
|---|---|---|---|
Age (years) | 50.3 ± 13.2 | 50.3 ± 13.6 | 0.007 |
Gender | |||
Female | 18,944 (71.189%) | 18,757 (70.486%) | 0.016 |
Male | 6876 (25.839%) | 7064 (26.545%) | 0.016 |
Race | |||
White | 14,565 (54.733%) | 14,589 (54.823%) | 0.002 |
Black | 5838 (21.938%) | 5796 (21.78%) | 0.004 |
Ethnicity | |||
Hispanic or Latino | 4135 (15.539%) | 4109 (15.441%) | 0.003 |
BMI | 39.8 ± 8.4 | 36.3 ± 7.5 | 0.439 |
Systemic Diagnoses | |||
Essential HTN | 15,741(59.2%) | 15,601 (58.6%) | 0.011 |
Type 1 DM | 1464 (5.5%) | 1347 (5.1%) | 0.020 |
Type II DM | 15,114 (56.8%) | 15,071 (56.6%) | 0.003 |
Long term use of insulin | 2169 (8.2%) | 2053 (7.7%) | 0.016 |
Hypercholesterolemia | 4254 (16.0%) | 4156 (15.6%) | 0.010 |
CAD | 1923 (7.2%) | 1893 (7.1%) | 0.004 |
Baseline DR | |||
Type 1 DM w/ Mild NPDR | 33 (0.1%) | 10 (0.0%) | 0.030 |
Type 2 DM w/ Mild NPDR | 207 (0.8%) | 161 (0.6%) | 0.021 |
Type 1 DM w/ Moderate NPDR | 10 (0.0%) | 10 (0.0%) | <0.001 |
Type 2 DM w/ Moderate NPDR | 50 (0.2%) | 37 (0.1%) | 0.012 |
Type 1 DM w/ Severe NPDR | 10 (0.0%) | 10 (0.0%) | <0.001 |
Type 2 DM w/ Severe NPDR | 29 (0.1%) | 12 (0.0%) | 0.023 |
Type 1 DM w/ PDR | 23 (0.1%) | 10 (0.0%) | 0.020 |
Type 2 DM w/ PDR | 78 (0.3%) | 46 (0.2%) | 0.025 |
Laboratory Values | |||
Hemoglobin A1c | 6.6 ± 1.7 | 7.2 ± 2.0 | 0.305 |
Serum Cholesterol | 178.0 ± 47.8 | 180.8 ± 49.0 | 0.058 |
